All content is for general information only — not medical advice, not a dosing or usage recommendation, and not a claim of efficacy. Many substances are not approved as medicines or are prescription-only; whether possession and use are legal depends on the law of your country of residence and is your own responsibility. myPeptides does not sell or supply any substances — it is an information and organization tool. For health questions, consult a licensed physician or pharmacist.
Peptide register
Every peptide covered here, with its mechanism class, legal status and WADA status. This is a status register, not a shop: no suppliers, no doses, no efficacy claims.
Class
Legal status
18 of 98
Bronchogen BRON
Khavinson tetrapeptide Ala-Glu-Asp-Leu, a supplement in Russia and a medicine nowhere; no registered trials, lung link shown in animals.
Registered in Russia as a dietary supplement; the Russian medicines register shows no registration
MonographCardiogen CARD
Khavinson short-peptide bioregulator (Ala-Glu-Asp-Arg); no registered human trials and no approval as a medicine.
MonographCartalax
Khavinson short-peptide bioregulator; no registered human trials and no approval as a medicine.
MonographChonluten
Khavinson bioregulator (Glu-Asp-Gly); its developers list it as a stomach and stress peptide, not a lung one; no trials, no approval.
MonographCortagen
Khavinson short-peptide bioregulator; no registered human trials and no approval as a medicine.
MonographCrystagen CRYS
Khavinson short-peptide bioregulator (Glu-Asp-Pro); no registered human trials and no approval as a medicine.
MonographEpitalon (epithalon)
Synthetic tetrapeptide from the Khavinson bioregulator series; no approval in any market.
MonographLivagen
Khavinson short-peptide bioregulator (Lys-Glu-Asp-Ala); no registered trials, no approval, the only human account is in a patent.
MonographN-Acetyl Epitalon Amidate NA-EPI
Acetylated and amidated Epitalon variant sold by vendors; no studies of its own, found in no database, and no approval.
This variant appears in no database, has no studies and no registration; the parent peptide epitalon is not a medicine anywhere
MonographOvagen
Khavinson short-peptide bioregulator (Glu-Asp-Leu); all reviewed work concerns the kidney, and there are no registered trials.
MonographPancragen PANC
Khavinson short-peptide bioregulator (Lys-Glu-Asp-Trp); no registered human trials and no approval as a medicine.
MonographPinealon
Khavinson short-peptide bioregulator; no registered human trials and no approval as a medicine.
MonographProstamax
Khavinson short-peptide bioregulator (Lys-Glu-Asp-Pro); no registered trials, no approval, and the subject of an FDA warning letter.
MonographTestagen
Khavinson bioregulator (Lys-Glu-Asp-Gly); sold as a testis peptide, but all peer-reviewed animal work concerns the pituitary and thyroid.
MonographThymalin
Polypeptide complex extracted from calf thymus, not a defined molecule; prescription medicine in Russia, not approved in any western market.
Approved in Russia only (Rx since 1982, re-registered 2024); FDA warning letter 2024 over US sales
MonographThymogen THYG
Synthetic dipeptide (Glu-Trp), also known as oglufanide; a registered medicine in Russia only, not approved in the EU or US.
Registered in Russia only, where the injection is prescription-only; no approval in the EU or US, and Western development was discontinued after a negative phase 3 trial
MonographVesugen
Synthetic Khavinson tripeptide (Lys-Glu-Asp); a food supplement in Russia, no medicine approval, and not the bovine vessel preparation.
MonographVilon
Khavinson dipeptide (Lys-Glu); submitted for medicine registration in Russia but never approved; on the market only as a food supplement.
MonographTake myPeptides with you
Track doses, plans and progress on your phone — end-to-end encrypted.
This article is for informational purposes only and does not replace medical advice. myPeptides gives no dosing recommendations.